Last reviewed · How we verify
NCT06837246
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
NA trial testing Cognitive Nutritional Supplement in Cognition in 422 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | Pharmavite LLC |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 422 |
| Start date | 24 February 2025 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cognitive Nutritional Supplement
- Placebo
Conditions studied
- Cognition — all drugs for Cognition →
- Concentration — all drugs for Concentration →
- Attention — all drugs for Attention →
- Focus — all drugs for Focus →
Sponsor
Pharmavite LLC — full company profile →
Who can join
Adults 25 to 65, any sex, with Cognition or Concentration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a double-blind, randomized, 12-week parallel study that aims to determine the effects of a cognitive nutritional supplement for 12 weeks on cognition parameters specific to attention/focus related domains, compared to a placebo control, in a general population of adult men and women in the United States.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06837246
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognition
Currently open trials in the same condition.
- NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
- NCT07109505 — Nutrition to Support Postoperative Recovery · NA · recruiting
- NCT07334392 — Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairm · NA · recruiting
- NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting
- NCT07231497 — Cognitive Strategies in Early Psychosis 1 · Phase 3 · recruiting
Other Pharmavite LLC trials
Trials by the same sponsor.
- NCT06935123 — Impact of Nutritional Supplementation on Sleep Quality · Phase 1 · completed
- NCT06611215 — Effect of a Nutritional Supplement on Gut Microbiota in Adults · NA · not yet recruiting
- NCT06058364 — Effect of a Nutritional Supplement on Mental Wellness in Adults · NA · completed
- NCT04067791 — A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melat · Phase 1 · completed
- NCT04516304 — A Nutritional Supplement on Vasomotor Symptoms in Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06837246 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pharmavite LLC
- Last refreshed: 15 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06837246.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing